Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
Background: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well cha...
Enregistré dans:
Auteurs principaux: | Nancy Luo, MD, MHS, Christopher M. O'Connor, MD, Karen Chiswell, PhD, Kevin J. Anstrom, PhD, L. Kristin Newby, MD, MHS, Robert J. Mentz, MD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6738d01874e04caa85a41cfa1501d83c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Automated Measurements of Left Ventricular Ejection Fraction and Volumes Using the EchoPAC System
par: Xiaoxue Chen, MD, Shaoling Yang, PhD, Qianqian He, MD, Yin Wang, PhD, Linyan Fan, MD, Fengling Wang, MD, Kun Zhao, MD, Jing Hu, MD
Publié: (2021) -
Short QT interval as a harbinger of an arrhythmogenic cardiomyopathy
par: Philippe Chevalier, MD, PhD, et autres
Publié: (2021) -
Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
par: Shinya Sugimoto, MD, PhD, et autres
Publié: (2022) -
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
par: Katsuhiro Yoshimura, MD, PhD, et autres
Publié: (2021) -
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
par: Kei Kunimasa, MD, PhD, et autres
Publié: (2021)